Nelson Ochekpe

Dr. Nelson Ochekpe

University of Jos

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2014 in Polymers
Verified
Journal Article
Open access
PDF file
NNNdidi C. Ngwuluka
Ndidi C. Ngwuluka
NONelson Ochekpe
Nelson Ochekpe
OAOkezie I. Aruoma
Okezie I. Aruoma
Naturapolyceutics defines the emerging science and technology platform that blends natural polymers and pharmaceutics for the design and development of drug delivery systems. Natural polymers due to their biological properties, sustainability, chemical flexibility, human and eco-friendliness are promising in this field. As drug delivery advances, there will be need for more polymers. Given that polymers utilized in pharmaceuticals require regulatory approval, robust processes are undertaken to facilitate the production of pharmaceutical grade natural polymers. This review provides insight into the processes—extraction, purification, modifications and characterizations—involved in the eventual utilization of natural polymers for drug delivery. The versatility of natural polymers and particularly modified natural polymers in targeted drug delivery, micro-/nano-drug delivery, theranostics, BioMEMs and generally in research and development of highly efficient, safe and quality products is demonstrated. Natural polymers are polymers of today and tomorrow. Therefore, the shift to undertake training, extensive research and subsequent commercialization of more natural polymers—novel and underutilized—for drug delivery is now!

1 October 2016 in Food Hydrocolloids
Verified
Journal Article
Closed access
ENElijah Nep
Elijah Nep
NNNdidi C. Ngwuluka
Ndidi C. Ngwuluka
CKChinwe U. Kemas
Chinwe U. Kemas
NONelson Ochekpe
Nelson Ochekpe

21 July 2013 in Journal of Polymers
Verified
Journal Article
Open access
PDF file
ENElijah Nep
Elijah Nep
POPatricia O. Odumosu
Patricia O. Odumosu
NNNdidi C. Ngwuluka
Ndidi C. Ngwuluka
POPatrick O. Olorunfemi
Patrick O. Olorunfemi
NONelson Ochekpe
Nelson Ochekpe
The use of naturally occurring biocompatible materials has been the focus of recent research activity in the design of dosage forms for immediate and controlled release formulations. Grewia gum is an intracellular gum obtained by extraction from the inner stem bark of the shrub Grewia mollis (Malvaceae). It grows abundantly (wild or cultivated) in the middle belt region of Nigeria, and the mucilage has been used by indigenes of this belt as thickener in soups. Grewia gum has been investigated for potential applications in pharmaceutical dosage forms. The industrial extrapolation of the applications of the gum has, however, been slowed by the limited structural, toxicological, and stability data available on the gum. This paper highlights ethnobotanical uses of G. mollis shrub and discusses the structural features, functional properties, and applications of grewia gum with emphases on its pharmaceutical potentials.

1 August 2021 in Vaccine
Verified
Journal Article
Open access
RGR.E. Guktur
R.E. Guktur
ENE.I. Nep
E.I. Nep
OAO. Asala
O. Asala
POP.O Olorunfemi
P.O Olorunfemi
NNN.C. Ngwuluka
N.C. Ngwuluka
ASA.S. Sagay
A.S. Sagay
Developing vaccine stabilizers from local natural sources is desirable especially if the stabilizer would enhance the ability of the antigen to withstand frequent failures in cold chains. The study was undertaken to formulate immunogenic live Newcastle Disease (ND) LaSota vaccines stabilized with modified native starches for use at cold and ambient temperatures and to assess the immunogenicity of the starch stabilized vaccines in vaccinated chickens. Native starch extracted from the tubers of Plectranthus esculentus (Family, Lamiaceae) was modified by carboxymethylation and acetylation/xerogel formation and used as vaccine stabilizers of ND LaSota virus with/without buffers/bulking excipients. Cold Chain Failure (CCF) was simulated by storing the vaccines at 5 ± 2 °C for one month then at 37 ± 1 °C for 96 h. The stability of the samples were evaluated in comparison with peptone stabilized ND vaccines using pH, residual moisture, XRD, reconstitution time, mean embryo infective dose (EID50) and haemagglutination (HA) tests. Haemagglutination inhibition was used to evaluate the efficacy of the vaccines in conferring positive serum antibody titers (≥23 log2) in vaccine-naïve 2-week old broilers that were orally administered a single dose of the vaccines kept at 37 ± 1 °C for 96 h and bled weekly over four weeks. Temperature, pH, moisture content and amorphousness impacted vaccine stability. Peptone stabilized vaccines were significantly less stable and most affected by temperature changes with 1.2log10EID50 loss while buffered/bulked trehalose, carboxymethylated and acetylated/xerogelized starch stabilized vaccines were most stable (0.2-0.5log10EID50 loss in titer) after 96 h in CCF. Buffered trehalose stabilized vaccine (TVB) had lower HA titres than peptone and starch stabilized vaccines containing D-mannitol and Na2HPO4. Antibody titres of vaccinated broilers were between 3.3 ± 1.398 and 8.35 ± 2.678. All the vaccines were immunogenic (HI ≥ 23) and developed HI titres (≥24) considered to be protective. Carboxymethylated and acetylated/xerogel derivatives of P. esculentus starch have a great potential as vaccine stabilizers especially in areas prone to CCF.

23 June 2022 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
RGRuth E. Guktur
Ruth E. Guktur
ENElijah I. Nep
Elijah I. Nep
CKChinwe U. Kemas
Chinwe U. Kemas
POPatrick O. Olorunfemi
Patrick O. Olorunfemi
NNNdidi C. Ngwuluka
Ndidi C. Ngwuluka
ASAtiene S. Sagay
Atiene S. Sagay

1 January 2012 in Dissolution Technologies
Verified
Journal Article
Open access
NONelson Ochekpe
Nelson Ochekpe
NNN. E. Ngwuluka
N. E. Ngwuluka
AAA. A. Agbowuro
A. A. Agbowuro
OOO. O. Obodozie
O. O. Obodozie